Cell-specific toxicity of short-term JUUL aerosol exposure to human bronchial epithelial cells and murine macrophages exposed at the airliquid interface
The following timeline depicts the overall progression of this process, including the estimated times when certain symptoms and reactions are likely to arise
However, the asthmatic airway epithelium shows exaggerated release of cytokines/chemokines, such as IL-6, CXCL8, and alarmins, including IL-25, TSLP, IL-33, in response to injury
With this issuance, these ZYN nicotine pouch products which have been authorized for sale in the United States since January 2025 may now be marketed with the following risk modification claim: "Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis." FDA authorizes 20 ZYN nicotine pouches be marketed with modified risk claim Dig deeper: An order permitting the sale of a modified risk tobacco product (MRTP) refers to specific products, not an entire class of tobacco products
Be ready for any emergency Download the official wikiHow Survival Guide to your phone so its ready before you need it
Lab Testing Transparency: This one is non-negotiable
